News
Merck & Company, Inc. (MRK) to acquire SpringWorks Therapeutics, Inc. (SWTX) for $47/share in cash, creating synergies for ...
Merck’s first-quarter net income increased as sales of its Keytruda cancer drug rose, but the Big Pharma company cut its 2025 ...
Merck is growing pharma sales and expanding margins, led by strong KEYTRUDA performance and cost discipline. Read more about ...
Merck said the expected tariff charge primarily reflects levies between the U.S. and China, but does not account for Trump’s planned pharmaceutical tariffs.
With potential tariffs and other drug pricing policies on the horizon, the industry is navigating uncertain waters. | The ...
Merck & Co., Inc. operates as a healthcare company ... Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services ...
Merck said it still expects 2025 total sales ... We sell different types of products and services to both investment professionals and individual investors. These products and services are ...
Merck's first-quarter net income increased as ... Sales of animal-health products, a category that has risen in significance in recent years alongside the number of pets in Americans' lives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback